https://news.medxy.ai/vi/prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients/Medxy AIvi2026-07-13T14:57:55-07:00Đánh giá sớm có hỗ trợ phần mềm giúp nâng cao khả năng dự đoán sống còn ở bệnh nhân bệnh ghép chống chủ mạn tính mới chẩn đoán https://news.medxy.ai/early-software-assisted-evaluation-enhances-prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients/Medxy AIen2026-07-13T14:57:17-07:00Early Software-Assisted Evaluation Enhances Prediction of Survival in Newly Diagnosed Chronic Graft-versus-Host Disease Patients https://news.medxy.ai/zh/cd7-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia/Medxy AIzh2026-07-13T14:44:54-07:00CD7靶向CAR-T细胞治疗复发/难治性CD7阳性急性髓系白血病：临床进展与未来展望 https://news.medxy.ai/ja/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-acute-myeloid-leukemia/Medxy AIja2026-07-13T14:44:29-07:00再発／難治性CD7陽性急性骨髄性白血病に対するCD7標的CAR-T細胞療法：臨床的進展と今後の展望 https://news.medxy.ai/vi/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia/Medxy AIvi2026-07-13T14:44:04-07:00Liệu pháp tế bào CAR-T hướng đích CD7 trong bệnh bạch cầu tủy cấp CD7 dương tính tái phát/kháng trị: tiến bộ lâm sàng và triển vọng tương lai https://news.medxy.ai/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia-clinical-advances-and-future-perspectives/Medxy AIen2026-07-13T14:43:08-07:00CD7-Directed CAR-T Cell Therapy in Relapsed/Refractory CD7-Positive Acute Myeloid Leukemia: Clinical Advances and Future Perspectives https://news.medxy.ai/zh/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma-3/Medxy AIzh2026-07-13T14:41:22-07:00BCMA靶向双特异性T细胞接合器pavurutamab：三类药物暴露后复发/难治性多发性骨髓瘤1/1b期研究结果令人鼓舞 https://news.medxy.ai/ja/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma-2/Medxy AIja2026-07-13T14:41:03-07:00BCMA標的二重特異性T細胞エンゲージャー・Pavurutamab：三剤群不応／再発多発性骨髄腫における第1/1b相で有望な結果 https://news.medxy.ai/vi/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma/Medxy AIvi2026-07-13T14:40:42-07:00Pavurutamab: thuốc dẫn đường tế bào T nhắm BCMA cho đa u tủy xương tái phát/kháng trị kháng ba nhóm thuốc — kết quả pha 1/1b đầy hứa hẹn https://news.medxy.ai/pavurutamab-a-bcma-targeting-bispecific-t-cell-engager-promising-phase-1-1b-results-in-triple-class-relapsed-refractory-multiple-myeloma/Medxy AIen2026-07-13T14:39:56-07:00Pavurutamab, a BCMA-Targeting Bispecific T-Cell Engager: Promising Phase 1/1b Results in Triple-Class Relapsed/Refractory Multiple Myeloma https://news.medxy.ai/zh/cardiac-alterations-in-swimming-induced-pulmonary-edema-4/Medxy AIzh2026-07-13T14:39:02-07:00游泳诱发性肺水肿中的心脏改变：急性评估的临床启示 https://news.medxy.ai/ja/cardiac-alterations-in-swimming-induced-pulmonary-edema-3/Medxy AIja2026-07-13T14:38:45-07:00水泳誘発性肺水腫に伴う心臓変化：急性評価に役立つ臨床的示唆 https://news.medxy.ai/vi/cardiac-alterations-in-swimming-induced-pulmonary-edema-2/Medxy AIvi2026-07-13T14:38:22-07:00Biến đổi tim trong phù phổi do bơi lội: Ý nghĩa lâm sàng đối với đánh giá cấp cứu https://news.medxy.ai/cardiac-alterations-in-swimming-induced-pulmonary-edema/Medxy AIen2026-07-13T14:37:39-07:00Cardiac Alterations in Swimming-Induced Pulmonary Edema: Clinical Implications for Acute Evaluation https://news.medxy.ai/zh/prostaglandin-i2-receptor-jun-p53-pathway-drives-alveolar-regeneration-for-lung-repair/Medxy AIzh2026-07-13T14:36:46-07:00激活前列腺素I2受体：通过JUN/p53通路促进肺泡再生的新机制 https://news.medxy.ai/ja/prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway-for-lung-repair/Medxy AIja2026-07-13T14:36:30-07:00肺再生を切り拓く新知見：プロスタグランジンI2受容体活性化がJUN/p53経路を介して肺胞再生を促進 https://news.medxy.ai/vi/prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway/Medxy AIvi2026-07-13T14:36:10-07:00Khởi động quá trình phục hồi phổi: Hoạt hóa thụ thể Prostaglandin I2 thúc đẩy tái tạo phế nang qua trục JUN/p53 https://news.medxy.ai/unlocking-lung-repair-prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway/Medxy AIen2026-07-13T14:35:32-07:00Unlocking Lung Repair: Prostaglandin I2 Receptor Activation Drives Alveolar Regeneration via JUN/p53 Pathway https://news.medxy.ai/ja/tomographic-predictors-of-foveal-versus-extrafoveal-atrophy-onset-in-age-related-macular-degeneration/Medxy AIja2026-07-13T14:34:18-07:00中等度加齢黄斑変性における中心窩先行・中心窩外先行萎縮を見分けるOCT予測因子：臨床的意義とバイオマーカーの示唆 https://news.medxy.ai/vi/tomographic-predictors-of-atrophy-onset-in-intermediate-age-related-macular-degeneration/Medxy AIvi2026-07-13T14:33:54-07:00Dự đoán bằng OCT về thời điểm khởi phát teo tại hố trung tâm và ngoài hố trung tâm trong thoái hóa điểm vàng do tuổi tác giai đoạn trung gian: ý nghĩa lâm sàng và giá trị biomarker https://news.medxy.ai/tomographic-predictors-of-foveal-versus-extrafoveal-atrophy-onset-in-intermediate-age-related-macular-degeneration/Medxy AIen2026-07-13T14:32:49-07:00Tomographic Predictors of Foveal Versus Extrafoveal Atrophy Onset in Intermediate Age-Related Macular Degeneration: Clinical Implications and Biomarker Insights https://news.medxy.ai/vi/ocular-symptom-trajectories-after-refractive-surgery/Medxy AIvi2026-07-13T14:28:03-07:00Đau mắt sau phẫu thuật khúc xạ: các quỹ đạo triệu chứng khác nhau và gợi ý cho chăm sóc hậu phẫu cá thể hóa https://news.medxy.ai/distinct-ocular-symptom-trajectories-after-refractive-surgery/Medxy AIen2026-07-13T14:27:18-07:00Distinct Ocular Symptom Trajectories After Refractive Surgery: Insights for Personalized Postoperative Care https://news.medxy.ai/ja/visual-electrophysiology-in-glaucoma-4/Medxy AIja2026-07-13T14:25:25-07:00緑内障における視覚電気生理学：2026年AAO報告の要点 https://news.medxy.ai/vi/visual-electrophysiology-in-glaucoma-3/Medxy AIvi2026-07-13T14:24:51-07:00Điện sinh lý thị giác trong glaucoma: Những điểm then chốt từ báo cáo năm 2026 của American Academy of Ophthalmology https://news.medxy.ai/zh/visual-electrophysiology-in-glaucoma-2/Medxy AIzh2026-07-13T14:24:24-07:00青光眼中的视觉电生理：2026年美国眼科学会报告要点 https://news.medxy.ai/visual-electrophysiology-in-glaucoma/Medxy AIen2026-07-13T14:23:01-07:00Visual Electrophysiology in Glaucoma: Key Findings from the 2026 American Academy of Ophthalmology Report https://news.medxy.ai/zh/hypoglossal-nerve-stimulation-lowers-obstructive-sleep-apnea-patients/Medxy AIzh2026-07-13T14:17:16-07:00舌下神经刺激显著降低缺氧负荷并改善阻塞性睡眠呼吸暂停患者嗜睡症状：STAR 试验新发现 https://news.medxy.ai/ja/hypoglossal-nerve-stimulation-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients/Medxy AIja2026-07-13T14:16:57-07:00舌下神経刺激療法は閉塞性睡眠時無呼吸の低酸素負荷を有意に低下させ、眠気も改善する：STAR試験からの知見 https://news.medxy.ai/vi/hypoglossal-nerve-stimulation-significantly-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients/Medxy AIvi2026-07-13T14:16:36-07:00Kích thích dây thần kinh hạ thiệt giúp giảm gánh nặng thiếu oxy và cải thiện buồn ngủ ở bệnh nhân ngưng thở khi ngủ tắc nghẽn: Phân tích từ thử nghiệm STAR https://news.medxy.ai/hypoglossal-nerve-stimulation-significantly-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients-insights-from-the-star-trial/Medxy AIen2026-07-13T14:15:54-07:00Hypoglossal Nerve Stimulation Significantly Lowers Hypoxic Burden and Improves Sleepiness in Obstructive Sleep Apnea Patients: Insights from the STAR Trial https://news.medxy.ai/zh/polysomnographic-characteristics-in-pediatric-obstructive-sleep-apnea/Medxy AIzh2026-07-13T14:14:32-07:00极端重度与极重度儿童阻塞性睡眠呼吸暂停的临床与多导睡眠监测特征差异 https://news.medxy.ai/ja/clinical-and-polysomnographic-characteristics-in-pediatric-obstructive-sleep-apnea/Medxy AIja2026-07-13T14:14:15-07:00小児の極重症OSAを見分ける臨床・PSG所見のポイント https://news.medxy.ai/vi/clinical-and-polysomnographic-characteristics-in-very-severe-pediatric-obstructive-sleep-apnea/Medxy AIvi2026-07-13T14:13:52-07:00Đặc điểm lâm sàng và đa ký giấc ngủ giúp phân biệt OSA tắc nghẽn cực kỳ nặng với rất nặng ở trẻ em https://news.medxy.ai/clinical-and-polysomnographic-characteristics-distinguishing-extreme-from-very-severe-pediatric-obstructive-sleep-apnea/Medxy AIen2026-07-13T14:13:12-07:00Clinical and Polysomnographic Characteristics Distinguishing Extreme from Very Severe Pediatric Obstructive Sleep Apnea https://news.medxy.ai/optimizing-prognostic-accuracy-in-duodenal-adenocarcinoma-evaluating-lymph-node-staging-schemes/Medxy AIen2026-07-13T14:06:21-07:00Optimizing Prognostic Accuracy in Duodenal Adenocarcinoma: Evaluating Lymph Node Staging Schemes and a Novel Nomogram https://news.medxy.ai/ja/nationwide-multimodal-prehabilitation-reduces-complications-in-colorectal-cancer-surgery/Medxy AIja2026-07-13T14:02:55-07:00大腸がん手術後の合併症を大幅に減らす全国的マルチモーダル・プレハビリテーション https://news.medxy.ai/vi/nationwide-multimodal-prehabilitation-reduces-complications-after-colorectal-cancer-surgery/Medxy AIvi2026-07-13T14:02:35-07:00Tiền phục hồi chức năng đa mô thức trên toàn quốc giúp giảm rõ rệt biến chứng sau phẫu thuật ung thư đại trực tràng https://news.medxy.ai/nationwide-multimodal-prehabilitation-significantly-reduces-complications-after-colorectal-cancer-surgery/Medxy AIen2026-07-13T14:01:50-07:00Nationwide Multimodal Prehabilitation Significantly Reduces Complications After Colorectal Cancer Surgery https://news.medxy.ai/zh/high-trauma-volume-hospitals-in-blunt-intestinal-injury/Medxy AIzh2026-07-13T14:00:31-07:00创伤量大的医院如何影响钝性肠损伤的及时手术管理 https://news.medxy.ai/ja/high-trauma-volume-hospitals-on-prompt-surgical-management-in-blunt-intestinal-injury/Medxy AIja2026-07-13T14:00:13-07:00外傷症例数の多い病院は鈍的腸損傷の迅速な手術管理にどう影響するか https://news.medxy.ai/vi/high-trauma-volume-hospitals-impact-on-prompt-surgical-management-in-blunt-intestinal-injury/Medxy AIvi2026-07-13T13:59:53-07:00Khối lượng chấn thương cao ở bệnh viện và tác động của nó đến xử trí phẫu thuật kịp thời trong tổn thương ruột kín https://news.medxy.ai/high-trauma-volume-hospitals-and-their-impact-on-prompt-surgical-management-in-blunt-intestinal-injury/Medxy AIen2026-07-13T13:59:12-07:00High Trauma Volume Hospitals and Their Impact on Prompt Surgical Management in Blunt Intestinal Injury https://news.medxy.ai/zh/assessing-readability-of-gynecologic-cancer-patient-education/Medxy AIzh2026-07-13T13:58:47-07:00妇科癌症患者教育材料可读性评估：弥合沟通鸿沟 https://news.medxy.ai/ja/readability-of-gynecologic-cancer-patient-education/Medxy AIja2026-07-13T13:58:30-07:00婦人科がん患者向け教育資料の可読性を検証する：コミュニケーション格差を埋めるために https://news.medxy.ai/vi/readability-of-gynecologic-cancer-patient-education-materials/Medxy AIvi2026-07-13T13:58:09-07:00Đánh giá mức độ dễ đọc của tài liệu giáo dục cho người bệnh ung thư phụ khoa: Thu hẹp khoảng cách giao tiếp https://news.medxy.ai/assessing-readability-of-gynecologic-cancer-patient-education-materials/Medxy AIen2026-07-13T13:57:29-07:00Assessing Readability of Gynecologic Cancer Patient Education Materials: Bridging the Communication Gap https://news.medxy.ai/zh/outcomes-of-retropubic-for-stress-urinary-incontinence/Medxy AIzh2026-07-13T13:50:45-07:00压力性尿失禁中段尿道吊带远期结局：耻骨后路径与经闭孔路径的再手术风险及并发症 https://news.medxy.ai/ja/long-term-outcomes-of-retropubic-for-stress-urinary-incontinence/Medxy AIja2026-07-13T13:50:25-07:00腹圧性尿失禁に対する恥骨後式と経閉鎖孔式中部尿道スリングの長期成績：再手術リスクと合併症 https://news.medxy.ai/vi/retropubic-vs-transobturator-midurethral-slings-for-stress-urinary-incontinence/Medxy AIvi2026-07-13T13:50:00-07:00Kết cục dài hạn của sling giữa niệu đạo đường sau xương mu so với đường xuyên lỗ bịt trong tiểu không tự chủ khi gắng sức: Nguy cơ phẫu thuật lại và biến chứng https://news.medxy.ai/long-term-outcomes-of-retropubic-vs-transobturator-midurethral-slings-for-stress-urinary-incontinence/Medxy AIen2026-07-13T13:49:11-07:00Long-Term Outcomes of Retropubic vs. Transobturator Midurethral Slings for Stress Urinary Incontinence: Reoperation Risks and Complications https://news.medxy.ai/vi/ischemic-placental-disease-for-neurological-and-psychiatric-disorders/Medxy AIvi2026-07-13T13:45:23-07:00Bệnh nhau thai thiếu máu cục bộ và nhập viện của mẹ vì rối loạn thần kinh, tâm thần: Tổng quan toàn diện https://news.medxy.ai/ischemic-placental-disease-and-maternal-hospitalization-for-neurological-and-psychiatric-disorders/Medxy AIen2026-07-13T13:44:12-07:00Ischemic Placental Disease and Maternal Hospitalization for Neurological and Psychiatric Disorders: A Comprehensive Review https://news.medxy.ai/zh/efficacy-of-native-tissue-hysteropexy-for-apical-pelvic-organ-prolapse/Medxy AIzh2026-07-13T13:38:27-07:00原位组织子宫固定术与子宫切除术治疗顶端盆腔器官脱垂：长期疗效与安全性比较 https://news.medxy.ai/ja/efficacy-and-safety-of-native-tissue-hysteropexy-for-apical-pelvic-organ-prolapse/Medxy AIja2026-07-13T13:38:09-07:00子宮温存術式はどこまで有利か？ 頂部骨盤臓器脱に対する native tissue hysteropexy と子宮摘出術の長期成績と安全性 https://news.medxy.ai/vi/efficacy-and-safety-of-native-tissue-hysteropexy-versus-hysterectomy-for-apical-pelvic-organ-prolapse/Medxy AIvi2026-07-13T13:37:47-07:00So sánh hiệu quả và độ an toàn dài hạn giữa hysteropexy bằng mô tự thân và cắt tử cung trong sa tạng chậu vùng đỉnh https://news.medxy.ai/comparing-long-term-efficacy-and-safety-of-native-tissue-hysteropexy-versus-hysterectomy-for-apical-pelvic-organ-prolapse/Medxy AIen2026-07-13T13:36:53-07:00Comparing Long-Term Efficacy and Safety of Native Tissue Hysteropexy Versus Hysterectomy for Apical Pelvic Organ Prolapse https://news.medxy.ai/zh/bile-acid-predict-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia/Medxy AIzh2026-07-13T11:27:46-07:00血清胆汁酸：胆道闭锁 Kasai 术后门静脉高压与食管静脉曲张的早期预测指标 https://news.medxy.ai/ja/serum-bile-acid-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia/Medxy AIja2026-07-13T11:27:27-07:00Kasai術後の胆道閉鎖症における門脈圧亢進症と食道静脈瘤を早期予測する血清胆汁酸 https://news.medxy.ai/vi/bile-acid-levels-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia/Medxy AIvi2026-07-13T11:27:05-07:00Axit mật huyết thanh: dấu ấn sớm dự báo tăng áp lực tĩnh mạch cửa và giãn tĩnh mạch thực quản sau phẫu thuật Kasai ở teo đường mật https://news.medxy.ai/serum-bile-acid-levels-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia/Medxy AIen2026-07-13T11:26:13-07:00Serum Bile Acid Levels as Early Predictors of Portal Hypertension and Esophageal Varices Post-Kasai in Biliary Atresia https://news.medxy.ai/vi/ibs-genetics-insights-into-cardiometabolic-and-triglyceride/Medxy AIvi2026-07-13T11:23:51-07:00Giải mã di truyền IBS: Các cơ chế liên quan tim mạch–chuyển hóa và triglyceride từ một phân tích gộp GWAS quy mô lớn https://news.medxy.ai/unraveling-ibs-genetics-insights-into-cardiometabolic-and-triglyceride-linked-mechanisms-from-a-large-gwas-meta-analysis/Medxy AIen2026-07-13T11:22:51-07:00Unraveling IBS Genetics: Insights into Cardiometabolic and Triglyceride-Linked Mechanisms from a Large GWAS Meta-Analysis https://news.medxy.ai/zh/dose-strategies-for-ustekinumab-in-crohns-disease/Medxy AIzh2026-07-13T11:19:36-07:00克罗恩病中乌司奴单抗剂量强化策略如何选择？REScUE试验带来新启示 https://news.medxy.ai/ja/dose-intensification-strategies-for-ustekinumab-in-crohns-disease/Medxy AIja2026-07-13T11:19:17-07:00クローン病におけるウステキヌマブ用量強化戦略を検証：REScUE試験からの知見 https://news.medxy.ai/vi/evaluating-dose-intensification-strategies-for-ustekinumab-in-crohns-disease/Medxy AIvi2026-07-13T11:18:57-07:00Đánh giá chiến lược tăng cường liều ustekinumab trong bệnh Crohn: Góc nhìn từ thử nghiệm REScUE https://news.medxy.ai/evaluating-dose-intensification-strategies-for-ustekinumab-in-crohns-disease-insights-from-the-rescue-trial/Medxy AIen2026-07-13T11:18:13-07:00Evaluating Dose Intensification Strategies for Ustekinumab in Crohn’s Disease: Insights from the REScUE Trial https://news.medxy.ai/zh/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy/Medxy AIzh2026-07-13T10:59:20-07:00女性卒中患者为何更容易漏筛大血管闭塞？——安大略省人群队列研究揭示血栓切除术结局的性别差异 https://news.medxy.ai/ja/sex-differences-in-large-vessel-occlusion-screening-thrombectomy-outcomes/Medxy AIja2026-07-13T10:59:01-07:00大血管閉塞スクリーニングと血栓回収療法転帰にみる性差：オンタリオ州の人口ベース・コホート研究からの示唆 https://news.medxy.ai/vi/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy-outcomes/Medxy AIvi2026-07-13T10:58:41-07:00Khác biệt giới trong sàng lọc tắc mạch lớn và kết quả thrombectomy: Góc nhìn từ nghiên cứu đoàn hệ dựa trên quần thể tại Ontario https://news.medxy.ai/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy-outcomes-insights-from-a-population-based-cohort-study-in-ontario/Medxy AIen2026-07-13T10:57:52-07:00Sex Differences in Large Vessel Occlusion Screening and Thrombectomy Outcomes: Insights from a Population-Based Cohort Study in Ontario https://news.medxy.ai/zh/premeal-insulin-enhances-postprandial-glucose-and-myocardial-microvascular-blood-flow-in-t1dm/Medxy AIzh2026-07-13T10:33:15-07:00餐前给胰岛素更关键：改善1型糖尿病餐后血糖控制与心肌微血管血流 https://news.medxy.ai/ja/premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-t1dm/Medxy AIja2026-07-13T10:32:57-07:00食前インスリンのタイミングが鍵：1型糖尿病における食後血糖と心筋微小循環を改善 https://news.medxy.ai/vi/premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-type-1-diabetes/Medxy AIvi2026-07-13T10:32:36-07:00Thời điểm dùng insulin rất quan trọng: Insulin trước bữa ăn cải thiện kiểm soát glucose sau ăn và tưới máu vi mạch cơ tim ở đái tháo đường type 1 https://news.medxy.ai/timing-matters-how-premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-type-1-diabetes/Medxy AIen2026-07-13T10:31:41-07:00Timing Matters: How Premeal Insulin Enhances Postprandial Glucose Control and Myocardial Microvascular Blood Flow in Type 1 Diabetes https://news.medxy.ai/zh/neurodevelopmental-outcomes-of-post-hysterosalpingography-with-iodinated-contrast/Medxy AIzh2026-07-12T20:29:29-07:00含碘造影剂子宫输卵管造影后受孕儿童的神经发育结局：一项关键队列分析 https://news.medxy.ai/ja/neurodevelopmental-outcomes-of-children-iodinated-contrast/Medxy AIja2026-07-12T20:29:12-07:00ヨード造影子宮卵管造影後に受胎した児の神経発達への影響：コホート研究の重要な検討 https://news.medxy.ai/vi/children-conceived-post-hysterosalpingography-with-iodinated-contrast/Medxy AIvi2026-07-12T20:28:53-07:00Phát hiện đáng lo ngại về phát triển thần kinh ở trẻ thụ thai sau chụp tử cung – vòi trứng với thuốc cản quang chứa iod https://news.medxy.ai/neurodevelopmental-outcomes-of-children-conceived-post-hysterosalpingography-with-iodinated-contrast/Medxy AIen2026-07-12T20:27:44-07:00Neurodevelopmental Outcomes of Children Conceived Post-Hysterosalpingography With Iodinated Contrast: A Critical Cohort Analysis https://news.medxy.ai/zh/hba1c-thresholds-for-accurate-type-1-diabetes-progression-risk-in-adults/Medxy AIzh2026-07-12T20:26:24-07:00校正年龄影响后，HbA1c 阈值更精准预测胰岛自身抗体阳性成人的 1 型糖尿病进展风险 https://news.medxy.ai/ja/hba1c-thresholds-for-accurate-type-1-diabetes-progression-risk/Medxy AIja2026-07-12T20:26:02-07:00膵島自己抗体陽性成人における1型糖尿病進行リスクを見極めるHbA1c閾値の再検討 https://news.medxy.ai/vi/refining-hba1c-thresholds-for-accurate-type-1-diabetes-progression-risk/Medxy AIvi2026-07-12T20:25:39-07:00Hiệu chỉnh ngưỡng HbA1c để dự đoán chính xác nguy cơ tiến triển đái tháo đường týp 1 ở người lớn dương tính với tự kháng thể đảo tụy https://news.medxy.ai/refining-hba1c-thresholds-for-accurate-type-1-diabetes-progression-risk-in-islet-autoantibody-positive-adults/Medxy AIen2026-07-12T20:24:34-07:00Refining HbA1c Thresholds for Accurate Type 1 Diabetes Progression Risk in Islet Autoantibody-Positive Adults https://news.medxy.ai/evaluating-the-impact-of-the-resuscitation-quality-improvement-program-on-in-hospital-cardiac-arrest-outcomes/Medxy AIen2026-07-12T20:22:46-07:00Evaluating the Impact of the Resuscitation Quality Improvement Program on In-Hospital Cardiac Arrest Outcomes https://news.medxy.ai/assessing-cardiovascular-risk-in-first-degree-relatives-of-individuals-with-elevated-lipoproteina/Medxy AIen2026-07-12T20:19:20-07:00Assessing Cardiovascular Risk in First-Degree Relatives of Individuals with Elevated Lipoprotein(a): Insights from a Swedish Cohort Study https://news.medxy.ai/zh/crhcp-trial-cardiovascular-health-post-antihypertensive-intervention/Medxy AIzh2026-07-12T20:17:06-07:00降压干预后心血管健康为何改善：来自CRHCP试验的启示 https://news.medxy.ai/ja/crhcp-trial-cardiovascular-health-improvements-post-antihypertensive-intervention/Medxy AIja2026-07-12T20:16:50-07:00降圧介入後の心血管健康改善を読み解く：CRHCP試験からの知見 https://news.medxy.ai/vi/cardiovascular-health-improvements-post-antihypertensive-intervention-the-crhcp-trial/Medxy AIvi2026-07-12T20:16:31-07:00Giải mã cải thiện sức khỏe tim mạch sau can thiệp tăng huyết áp: Góc nhìn từ thử nghiệm CRHCP https://news.medxy.ai/unraveling-cardiovascular-health-improvements-post-antihypertensive-intervention-insights-from-the-crhcp-trial/Medxy AIen2026-07-12T20:15:38-07:00Unraveling Cardiovascular Health Improvements Post-Antihypertensive Intervention: Insights from the CRHCP Trial https://news.medxy.ai/zh/durvalumab-%e8%81%94%e5%90%88%e5%8c%96%e7%96%97%e5%bb%b6%e9%95%bf%e6%99%9a%e6%9c%9f%e8%83%86%e9%81%93%e7%99%8c%e7%94%9f%e5%ad%98%ef%bc%9atopaz-1-%e8%af%95%e9%aa%8c4%e5%b9%b4%e4%ba%8b%e5%90%8e%e5%88%86/Medxy AIzh2026-07-12T20:12:55-07:00Durvalumab 联合化疗延长晚期胆道癌生存：TOPAZ-1 试验4年事后分析揭示长期获益 https://news.medxy.ai/ja/durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer-2/Medxy AIja2026-07-12T20:12:37-07:00進行胆道癌の生存を延長：TOPAZ-1試験4年post hoc解析が示したDurvalumab併用化学療法の意義 https://news.medxy.ai/vi/durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer/Medxy AIvi2026-07-12T20:12:17-07:00Durvalumab phối hợp hóa trị giúp kéo dài sống còn ở ung thư đường mật tiến triển: Kết quả phân tích hậu kiểm 4 năm từ thử nghiệm TOPAZ-1 https://news.medxy.ai/durvalumab-plus-chemotherapy-extends-survival-in-advanced-biliary-tract-cancer/Medxy AIen2026-07-12T20:11:17-07:00Durvalumab Plus Chemotherapy Extends Survival in Advanced Biliary Tract Cancer: Insights from the TOPAZ-1 Trial Four-Year Post Hoc Analysis https://news.medxy.ai/zh/long-term-management-in-moderate-to-severe-atopic-dermatitis-real-world-evidence-on-24-week-abrocitinib/Medxy AIzh2026-07-12T19:07:13-07:00中重度特应性皮炎长期管理优化：abrocitinib 24 周减量策略的真实世界证据 https://news.medxy.ai/ja/long-term-management-in-moderate-to-severe-atopic-dermatitis-real-world-evidence-on-24-week-abrocitinib-tapering/Medxy AIja2026-07-12T19:06:55-07:00中等症から重症アトピー性皮膚炎の長期管理を最適化する：アブロシチニブ24週間漸減の実臨床エビデンス https://news.medxy.ai/vi/long-term-management-in-moderate-to-severe-atopic-dermatitis/Medxy AIvi2026-07-12T19:06:34-07:00Tối ưu hóa điều trị duy trì dài hạn trong viêm da cơ địa mức độ trung bình đến nặng: Bằng chứng thực tế về chiến lược giảm dần abrocitinib trong 24 tuần https://news.medxy.ai/optimizing-long-term-management-in-moderate-to-severe-atopic-dermatitis/Medxy AIen2026-07-12T19:05:23-07:00Optimizing Long-Term Management in Moderate-to-Severe Atopic Dermatitis: Real-World Evidence on 24-Week Abrocitinib Tapering Strategies https://news.medxy.ai/vi/consensus-on-staging-and-surveillance-imaging-for-cutaneous-squamous-cell-carcinoma/Medxy AIvi2026-07-12T19:02:42-07:00Khi nào cần chụp hình ảnh? Đồng thuận chuyên gia về đánh giá giai đoạn và theo dõi CSCC https://news.medxy.ai/zh/expert-consensus-on-staging-and-surveillance-imaging-for-cutaneous-squamous-cell-carcinoma/Medxy AIzh2026-07-12T19:02:06-07:00何时进行影像学检查：皮肤鳞状细胞癌分期与监测影像学的专家共识 https://news.medxy.ai/when-to-image-expert-consensus-on-staging-and-surveillance-imaging-for-cutaneous-squamous-cell-carcinoma/Medxy AIen2026-07-12T19:00:23-07:00When to Image: Expert Consensus on Staging and Surveillance Imaging for Cutaneous Squamous Cell Carcinoma https://news.medxy.ai/feasibility-and-comparative-outcomes-of-24-week-abrocitinib-tapering-in-moderate-to-severe-atopic-dermatitis/Medxy AIen2026-07-12T18:51:45-07:00Feasibility and Comparative Outcomes of 24-Week Abrocitinib Tapering in Moderate-to-Severe Atopic Dermatitis https://news.medxy.ai/zh/high-frequency-ultrasound-in-palpable-indurations-after-cosmetic-filler-injections/Medxy AIzh2026-07-12T18:50:53-07:00高频超声在化妆品填充剂注射后可触及硬结管理中的应用：精准诊断与影像引导治疗 https://news.medxy.ai/ja/high-frequency-ultrasound-in-managing-palpable-indurations/Medxy AIja2026-07-12T18:50:36-07:00美容フィラー注入後の触知可能な硬結の管理における高周波超音波：診断精度と超音波ガイド下治療 https://news.medxy.ai/vi/high-frequency-ultrasound-in-managing-palpable-indurations-after-cosmetic/Medxy AIvi2026-07-12T18:50:18-07:00Siêu âm tần số cao trong xử trí tình trạng cứng nắn sờ thấy sau tiêm chất làm đầy thẩm mỹ: độ chính xác chẩn đoán và điều trị dưới hướng dẫn hình ảnh https://news.medxy.ai/high-frequency-ultrasound-in-managing-palpable-indurations-after-cosmetic-filler-injections/Medxy AIen2026-07-12T18:49:25-07:00High-Frequency Ultrasound in Managing Palpable Indurations After Cosmetic Filler Injections: Diagnostic Precision and Guided Therapeutics https://news.medxy.ai/comparative-efficacy-and-pragmatic-implications-of-walant-versus-general-and-regional-anesthesia-in-flexor-tendon-repair/Medxy AIen2026-07-12T18:46:21-07:00WAFER Trial and Beyond: Comparative Efficacy and Pragmatic Implications of WALANT versus General and Regional Anesthesia in Flexor Tendon Repair https://news.medxy.ai/integrating-trauma-focused-therapy-with-cognitive-behavioural-therapy-for-psychosis-insights-from-star-trial/Medxy AIen2026-07-12T18:45:57-07:00创伤聚焦治疗整合 CBTp：STAR 试验及相关研究带来的启示 https://news.medxy.ai/ja/integrating-trauma-focused-therapy-with-cognitive-behavioural-therapy-for-psychosis/Medxy AIja2026-07-12T18:45:34-07:00精神病症状に対するトラウマ焦点化療法と認知行動療法の統合：STAR試験と関連研究からの知見 https://news.medxy.ai/vi/integrating-trauma-focused-therapy-with-cognitive-behavioural-therapy-for-psychosis-from-the-star-trial/Medxy AIvi2026-07-12T18:45:09-07:00Kết hợp trị liệu tập trung vào sang chấn với liệu pháp nhận thức – hành vi cho loạn thần: Những hiểu biết từ thử nghiệm STAR và các nghiên cứu liên quan https://news.medxy.ai/integrating-trauma-focused-therapy-with-cognitive-behavioural-therapy-for-psychosis-insights/Medxy AIen2026-07-12T18:43:52-07:00Integrating Trauma-Focused Therapy with Cognitive Behavioural Therapy for Psychosis: Insights from the STAR Trial and Related Research https://news.medxy.ai/ja/adolescent-mental-health-care-and-stigma-from-the-artemis-trial/Medxy AIja2026-07-12T18:41:30-07:00思春期メンタルヘルスケアとスティグマ：ARTEMIS無作為化臨床試験と関連エビデンスからの示唆 https://news.medxy.ai/vi/adolescent-mental-health-care-and-stigma-from-the-artemis-randomized-clinical-trial/Medxy AIvi2026-07-12T18:41:08-07:00Chăm sóc sức khỏe tâm thần vị thành niên và kỳ thị: Góc nhìn từ thử nghiệm lâm sàng ngẫu nhiên ARTEMIS và các bằng chứng liên quan https://news.medxy.ai/adolescent-mental-health-care-and-stigma/Medxy AIen2026-07-12T18:39:37-07:00Adolescent Mental Health Care and Stigma: Insights from the ARTEMIS Randomized Clinical Trial and Complementary Evidence https://news.medxy.ai/zh/the-abcdef-bundle-on-delirium-functional-status-and-quality-of-life/Medxy AIzh2026-07-12T18:39:17-07:00澳大利亚 ICU 中 ABCDEF 方案的效果评估：对谵妄、功能状态及长期生活质量的影响 https://news.medxy.ai/ja/the-abcdef-bundle-impacts-on-delirium-functional-status-and-quality-of-life/Medxy AIja2026-07-12T18:39:01-07:00オーストラリアICUでABCDEFバンドルを評価：せん妄、機能、長期QOLへの影響 https://news.medxy.ai/vi/the-abcdef-bundle-impacts-on-delirium-functional-status-and-long-term-quality-of-life/Medxy AIvi2026-07-12T18:38:44-07:00Đánh giá gói ABCDEF tại các ICU ở Australia: Tác động lên mê sảng, tình trạng chức năng và chất lượng cuộc sống dài hạn https://news.medxy.ai/abcdef-bundle-in-icus-impacts-on-delirium-functional-status/Medxy AIen2026-07-12T18:38:08-07:00Evaluating the ABCDEF Bundle in Australian ICUs: Impacts on Delirium, Functional Status, and Long-Term Quality of Life https://news.medxy.ai/zh/staffing-model-cuts-length-of-stay-in-transforming-emergency-psychiatric-care/Medxy AIzh2026-07-12T18:37:32-07:00重塑精神科急诊服务：一种新型排班模式如何缩短停留时间 https://news.medxy.ai/ja/transforming-emergency-psychiatric-care-staffing-model-cuts-length-of-stay/Medxy AIja2026-07-12T18:37:17-07:00精神科救急を変える新戦略：新たなスタッフ配置モデルが滞在時間を短縮 https://news.medxy.ai/vi/emergency-psychiatric-care/Medxy AIvi2026-07-12T18:36:59-07:00Tái cấu trúc chăm sóc tâm thần cấp cứu: mô hình nhân sự mới giúp rút ngắn thời gian lưu viện https://news.medxy.ai/transforming-emergency-psychiatric-care/Medxy AIen2026-07-12T18:36:18-07:00Transforming Emergency Psychiatric Care: How a Novel Staffing Model Cuts Length of Stay https://news.medxy.ai/zh/contraceptive-access-in-veterans-affairs-pharmacist-led-hormonal-contraception-provision-and-12-month-dispensing-pilot/Medxy AIzh2026-07-12T18:32:57-07:00拓展退伍军人事务部避孕服务：药师主导的激素避孕药服务与12个月发药试点 https://news.medxy.ai/ja/pharmacist-led-hormonal-contraception-provision-and-12-month-dispensing-pilot/Medxy AIja2026-07-12T18:32:40-07:00VAで広がる避妊アクセス：薬剤師主導のホルモン避妊薬提供と12か月分調剤のパイロット研究 https://news.medxy.ai/vi/expanding-contraceptive-access-in-veterans-affairs-pharmacist-led-hormonal-contraception-provision/Medxy AIvi2026-07-12T18:32:18-07:00Mở rộng tiếp cận tránh thai trong hệ thống Cựu chiến binh: thí điểm dược sĩ kê đơn thuốc tránh thai nội tiết và cấp phát 12 tháng https://news.medxy.ai/expanding-contraceptive-access-in-veterans-affairs-pharmacist-led-hormonal-contraception-provision-and-12-month-dispensing-pilot/Medxy AIen2026-07-12T18:31:37-07:00Expanding Contraceptive Access in Veterans Affairs: Pharmacist-Led Hormonal Contraception Provision and 12-Month Dispensing Pilot https://news.medxy.ai/patient-centered-prescription-opioid-tapering-rct/Medxy AIen2026-07-12T18:30:19-07:00Patient-Centered Prescription Opioid Tapering: Evidence from a Multisite Randomized Clinical Trial and Complementary Digital Interventions https://news.medxy.ai/vi/fludarabine-with-treosulfan-vs-total-body-irradiation/Medxy AIvi2026-07-12T14:08:57-07:00Fludarabine phối hợp Treosulfan hay chiếu xạ toàn thân: So sánh hồi cứu các phác đồ điều kiện hóa trong ghép ALL https://news.medxy.ai/fludarabine-with-treosulfan-vs-total-body-irradiation-as-conditioning-in-all-transplantation/Medxy AIen2026-07-12T14:08:23-07:00Fludarabine with Treosulfan vs. Total Body Irradiation as Conditioning in ALL Transplantation: A Comparative Retrospective Analysis https://news.medxy.ai/zh/mpl-and-sh2b3-in-triple-negative-thrombocytosis/Medxy AIzh2026-07-12T14:06:19-07:00三阴性血小板增多症的遗传驱动因素：MPL 与 SH2B3/LNK 突变的临床意义 https://news.medxy.ai/ja/mpl-and-sh2b3-lnk-mutations-in-triple-negative-thrombocytosis/Medxy AIja2026-07-12T14:06:05-07:00トリプルネガティブ血小板増多症の遺伝学的背景を解明する：MPLおよびSH2B3/LNK変異の意義 https://news.medxy.ai/vi/genetic-drivers-in-triple-negative-thrombocytosis-mpl-and-sh2b3-lnk-mutations/Medxy AIvi2026-07-12T14:05:49-07:00Giải mã các yếu tố di truyền thúc đẩy tăng tiểu cầu âm tính bộ ba: Ý nghĩa của đột biến MPL và SH2B3/LNK https://news.medxy.ai/unraveling-genetic-drivers-in-triple-negative-thrombocytosis/Medxy AIen2026-07-12T14:05:17-07:00Unraveling Genetic Drivers in Triple Negative Thrombocytosis: Implications of MPL and SH2B3/LNK Mutations https://news.medxy.ai/zh/maipi-for-mantle-cell-lymphoma/Medxy AIzh2026-07-12T09:32:18-07:00MAIPI：基于常规组织学的套细胞淋巴瘤 AI 预后新指标 https://news.medxy.ai/ja/maipi-for-mantle-cell-lymphoma-using-routine-histology/Medxy AIja2026-07-12T09:32:02-07:00MAIPI：日常病理だけで予後を見通す、マントル細胞リンパ腫向け新規AI予後指標 https://news.medxy.ai/vi/maipi-prognostic-index-for-mantle-cell-lymphoma-using-routine-histology/Medxy AIvi2026-07-12T09:31:45-07:00MAIPI: Chỉ số tiên lượng mới dựa trên AI cho u lympho tế bào áo choàng từ mô học thường quy https://news.medxy.ai/maipi-a-novel-ai-powered-prognostic-index-for-mantle-cell-lymphoma-using-routine-histology/Medxy AIen2026-07-12T09:30:49-07:00MAIPI: A Novel AI-Powered Prognostic Index for Mantle Cell Lymphoma Using Routine Histology https://news.medxy.ai/zh/piezo1-variants-precision-into-hereditary-red-blood-cell-and-iron-disorders/Medxy AIzh2026-07-12T09:27:21-07:00PIEZO1变异解读新视角：遗传性红细胞与铁代谢疾病的精准分型 https://news.medxy.ai/ja/piezo1-variants-into-red-blood-cell-and-iron-disorders/Medxy AIja2026-07-12T09:27:08-07:00PIEZO1バリアントを読み解く：遺伝性赤血球・鉄代謝異常における精密理解 https://news.medxy.ai/vi/decoding-piezo1-variants-precision-into-hereditary-red-blood-cell-and-iron-disorders/Medxy AIvi2026-07-12T09:26:49-07:00Giải mã các biến thể PIEZO1: Những hiểu biết chính xác về rối loạn hồng cầu và chuyển hóa sắt di truyền https://news.medxy.ai/decoding-piezo1-variants-precision-insights-into-hereditary-red-blood-cell-and-iron-disorders/Medxy AIen2026-07-12T09:25:50-07:00Decoding PIEZO1 Variants: Precision Insights into Hereditary Red Blood Cell and Iron Disorders